#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polycystic liver disease Erythema Diabetes insipidus Oesophageal adenocarcinoma stage III Prader-Willi syndrome Congenital growth hormone deficiency Vulval cancer Rectal cancer Osteomyelitis Chronic graft versus host disease in liver Autoimmune myositis Neuroendocrine tumour Oropharyngeal cancer recurrent Demyelination Acquired ATTR amyloidosis More trials…

    Learn about Rare Diseases

    Krabbe’s disease – Basic Information Advanced systemic mastocytosis – Trials in Disease Glycogen storage disease type II – Basic Information Isodicentric chromosome 15 syndrome – Diagnostics Malignant fibrous histiocytoma – Trials in Disease Bronchiolitis obliterans syndrome – Life with Disease Congenital generalised lipodystrophy – Trials in Disease Mantle cell lymphoma stage III – Diagnostics Idiopathic inflammatory myopathy – Diagnostics Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cedazuridine Quetiapine Vigabatrin Ceftolozane Triglycerides, Medium Chain Garadacimab Buprenorphine Psma-11 Aliskiren Alizapride Patiromer Degarelix Danicamtiv Toripalimab Interferon Alfa Dinutuximab Beta Munc-Cd34 Tetrahydrouridine Amb-05X Busulfan More therapies…

    Learn about Your Condition

    Rubella Ischaemic stroke Malignant lymphoid neoplasm Eosinophilic gastritis Fatty acid oxidation disorder Cough Neuralgia Hypogonadism male Lymphangiosarcoma Endocrine ophthalmopathy Renal cancer stage IV Wolfram syndrome Immune-mediated renal disorder Bronchostenosis Idiopathic pulmonary fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Jules Bordet

Institut Jules Bordet

Mijlenmeersstraat 90, Anderlecht, 1070, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Brimonidine Tartrate
    • Dexamethasone
    • Dextran 70
    Austria Belgium Czechia Finland France Germany +7

  • Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Infliximab
    Belgium Denmark France Germany Italy The Netherlands +3

  • Study Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Docetaxel
    Belgium Czechia Denmark Finland Germany Hungary +7

  • Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Anakinra
    • Buclizine Hydrochloride
    • Codeine Phosphate
    Austria Belgium Czechia France Germany Italy +2

  • Study on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    Belgium France Spain

  • Study on Swallowing and Quality of Life in Advanced Head and Neck Cancer Patients Using Cisplatin and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Oropharyngeal cancer
    Investigated Drugs:
    • Barium Sulfate
    • Cisplatin
    • Fludeoxyglucose (18F)
    Belgium

  • Study on SOT102 for Patients with Advanced Gastric and Pancreatic Cancer, Alone or with Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Gemcitabine
    Belgium Czechia France Spain

  • Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Bevacizumab
    • Paclitaxel
    Belgium Denmark Finland France Germany Ireland +4

  • Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lenalidomide
    • Obinutuzumab
    • Rituximab
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Shortening Antibiotic Treatment for Febrile Neutropenia in Hematology Patients Using Cefepime and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Febrile neutropenia
    Investigated Drugs:
    • Cefepime
    • Ceftazidime
    • Imipenem
    Belgium
Previous Page
1 … 18 19 20 21 22
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!